Schedule 13D ownership disclosure
ACRO BIOMEDICAL CO., LTD.
Security class unavailable · CUSIP: 004892105
Event date: 2020-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 62.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001640334-21-000454
- Form type
- SC 13D
- Filer
- ACRO BIOMEDICAL CO., LTD.
- CIK
- CIK 1622996
- Filed
- Feb 26, 2021
- Reporting period
- Nov 07, 2020
- Description
- Schedule 13D beneficial ownership